These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32933879)

  • 1. Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma.
    Yasuda H; Tsukune Y; Watanabe N; Sugimoto K; Uchimura A; Tateyama M; Miyashita Y; Ochi Y; Komatsu N
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):774-776. PubMed ID: 32933879
    [No Abstract]   [Full Text] [Related]  

  • 2. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 3. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(697):1220-1221. PubMed ID: 32520467
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 antibody performances: we need better criteria.
    Galli C; Plebani M
    Clin Chem Lab Med; 2020 Sep; 58(12):e303-e305. PubMed ID: 32970607
    [No Abstract]   [Full Text] [Related]  

  • 7. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
    Padoan A; Zuin S; Cosma C; Basso D; Plebani M; Bonfante F
    Clin Chim Acta; 2020 Nov; 510():654-655. PubMed ID: 32818490
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
    Roeker LE; Knorr DA; Pessin MS; Ramanathan LV; Thompson MC; Leslie LA; Zelenetz AD; Mato AR
    Leukemia; 2020 Nov; 34(11):3047-3049. PubMed ID: 32855439
    [No Abstract]   [Full Text] [Related]  

  • 11. The early antibody response to SARS-Cov-2 infection.
    Dittadi R; Afshar H; Carraro P
    Clin Chem Lab Med; 2020 Sep; 58(10):e201-e203. PubMed ID: 32639941
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 13. The Many Faces of COVID-19: Atypical Presentation of COVID-19 in a Patient With Crohn's Disease With Acute Diarrhea Leading to Severe Hypovolemic Hyponatremia-A Case Report.
    Mansoor E; Khoudari G; Abou Saleh M; Elfadawy N; Cooper GS; Katz J; Faulx A
    Am J Gastroenterol; 2020 Oct; 115(10):1730-1731. PubMed ID: 32826570
    [No Abstract]   [Full Text] [Related]  

  • 14. Labs scramble to produce new coronavirus diagnostics.
    Cohen J; Kupferschmidt K
    Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
    [No Abstract]   [Full Text] [Related]  

  • 15. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-glomerular basement membrane disease during the COVID-19 pandemic.
    Prendecki M; Clarke C; Cairns T; Cook T; Roufosse C; Thomas D; Willicombe M; Pusey CD; McAdoo SP
    Kidney Int; 2020 Sep; 98(3):780-781. PubMed ID: 32599088
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
    Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
    Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
    Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.